Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Le Page

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
JAMA Neurology|July 1, 2024
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Brain : a Journal of Neurology|December 21, 2014
Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patientsXavier Ayrignac, Clarisse Carra-Dalliere, Nicolas Menjot de Champfleur, et al.
CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
JAMA Neurology|July 1, 2024
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple SclerosisAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Brain : a Journal of Neurology|December 21, 2014
Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patientsXavier Ayrignac, Clarisse Carra-Dalliere, Nicolas Menjot de Champfleur, et al.
CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.
Pageof 7